LIDOCAINE - TO TAPER OR NOT TO TAPER

被引:2
作者
REID, PR
机构
[1] JOHNS HOPKINS HOSP,DIV CARDIOL,BALTIMORE,MD 21205
[2] JOHNS HOPKINS HOSP,DIV CLIN PHARMACOL,BALTIMORE,MD 21205
关键词
D O I
10.1002/j.1552-4604.1976.tb01511.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:162 / 164
页数:3
相关论文
共 8 条
[1]   INTRAMUSCULAR LIDOCAINE IN THERAPY OF VENTRICULAR ARRHYTHMIAS [J].
BELLET, S ;
ROMAN, L ;
KOSTIS, JB ;
FLEISCHM.D .
AMERICAN JOURNAL OF CARDIOLOGY, 1971, 27 (03) :291-+
[2]  
BOYES RN, 1971, LIDOCAINE TREATMENT, P140
[3]   CLINICAL PHARMACOLOGY OF LIDOCAINE AS AN ANTIARRHYTHMIC DRUG [J].
COLLINSWORTH, KA ;
KALMAN, SM ;
HARRISON, DC .
CIRCULATION, 1974, 50 (06) :1217-1230
[4]   EFFECT OF LIDOCAINE ON VENTRICULAR ARRHYTHMIAS IN PATIENTS WITH CORONARY HEART DISEASE [J].
GIANELLY, R ;
VONDERGR.JO ;
SPIVACK, AP ;
HARRISON, DC .
NEW ENGLAND JOURNAL OF MEDICINE, 1967, 277 (23) :1215-&
[5]  
JEWITT DE, 1968, LANCET, V1, P266
[6]  
ROWLAND M, 1974, CLIN PHARMACOKINETIC, P59
[7]   INFLUENCE OF HEART FAILURE, LIVER DISEASE, AND RENAL FAILURE ON DISPOSITION OF LIDOCAINE IN MAN [J].
THOMSON, PD ;
ROWLAND, M ;
MELMON, KL .
AMERICAN HEART JOURNAL, 1971, 82 (03) :417-&
[8]  
WU D, 1975, DRUGS CARDIOLOGY 1, V1, P43